PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000975300.66917.8b |
_version_ | 1797281538812936192 |
---|---|
author | Irene Strassl Sigrid Machherndl-Spandl Veronika Buxhofer-Ausch Michaela Binder Olga Stiefel Robert Milanov Emine Kaynak Michael Girschikofsky Andreas Petzer Johannes Clausen |
author_facet | Irene Strassl Sigrid Machherndl-Spandl Veronika Buxhofer-Ausch Michaela Binder Olga Stiefel Robert Milanov Emine Kaynak Michael Girschikofsky Andreas Petzer Johannes Clausen |
author_sort | Irene Strassl |
collection | DOAJ |
first_indexed | 2024-03-07T16:58:57Z |
format | Article |
id | doaj.art-5e6852e46ffb4cfe8bb236f039a4f0d3 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:58:57Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-5e6852e46ffb4cfe8bb236f039a4f0d32024-03-03T03:25:51ZengWileyHemaSphere2572-92412023-08-017e669178b10.1097/01.HS9.0000975300.66917.8b202308003-01999PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCEIrene Strassl0Sigrid Machherndl-Spandl1Veronika Buxhofer-Ausch2Michaela Binder3Olga Stiefel4Robert Milanov5Emine Kaynak6Michael Girschikofsky7Andreas Petzer8Johannes Clausen91 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austria1 Ordensklinikum Linz Elisabethinen, Linz, Austriahttp://journals.lww.com/10.1097/01.HS9.0000975300.66917.8b |
spellingShingle | Irene Strassl Sigrid Machherndl-Spandl Veronika Buxhofer-Ausch Michaela Binder Olga Stiefel Robert Milanov Emine Kaynak Michael Girschikofsky Andreas Petzer Johannes Clausen PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE HemaSphere |
title | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
title_full | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
title_fullStr | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
title_full_unstemmed | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
title_short | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
title_sort | pb2134 bcma targeted therapies in patients with relapsed refractory multiple myeloma after allogeneic stem cell transplantation a single center experience |
url | http://journals.lww.com/10.1097/01.HS9.0000975300.66917.8b |
work_keys_str_mv | AT irenestrassl pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT sigridmachherndlspandl pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT veronikabuxhoferausch pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT michaelabinder pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT olgastiefel pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT robertmilanov pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT eminekaynak pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT michaelgirschikofsky pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT andreaspetzer pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT johannesclausen pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience |